Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
about
Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness.Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic
P2860
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nociceptin/orphanin FQ (N/OFQ) ...... et for the treatment of asthma
@en
Nociceptin/orphanin FQ
@nl
type
label
Nociceptin/orphanin FQ (N/OFQ) ...... et for the treatment of asthma
@en
Nociceptin/orphanin FQ
@nl
prefLabel
Nociceptin/orphanin FQ (N/OFQ) ...... et for the treatment of asthma
@en
Nociceptin/orphanin FQ
@nl
P2093
P2860
P50
P356
P1476
Nociceptin/orphanin FQ (N/OFQ) ...... et for the treatment of asthma
@en
P2093
Antonella De Angelis
Bruno D'Agostino
Christopher E Brightling
Francesco Rossi
Girolamo Calò
John McDonald
Konrad Urbanek
Lucy Woodman
Maria Matteis
Mitesh Pancholi
P2860
P304
P356
10.1111/BPH.13416
P407
P577
2016-01-12T00:00:00Z